InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Smith Sean Michael. Officer active across 1 company, notably Neoleukin Therapeutics, Inc.. Aggregated, 3 reports have been published. History available since 10 August 2022. The latest transaction was disclosed on 10 August 2023 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
3 of 3 declarations